Literature DB >> 10228902

Regulation of CA 125 expression in cultured human carcinoma cells.

C Marth1, A G Zeimet, M Widschwendter, G Daxenbichler.   

Abstract

CA 125 shedding is not a constitutive and stable process but may be affected by cell cycle and cell proliferation as well as by various growth factors and cytokines. Interferons, interleukin-1 beta, tumor necrosis factor-alpha and transforming growth factor-alpha have been shown to induce while glucocorticoids and transforming growth factor-beta have been shown to suppress the release of the tumor marker CA 125 from ovarian carcinoma cells. Several endogenous as well as exogenous factors may affect CA 125 biosynthesis; however, a major question remains whether this observed modulation of CA 125 expression in vitro is of clinical importance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10228902

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  3 in total

1.  Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.

Authors:  Nathalie Scholler; Barbara Garvik; Martha Hayden-Ledbetter; Toni Kline; Nicole Urban
Journal:  Cancer Lett       Date:  2006-05-04       Impact factor: 8.679

2.  Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?

Authors:  Julio Núñez; Eduardo Núñez; Luciano Consuegra; Juan Sanchis; Vicent Bodí; Angel Martínez-Brotons; Vicente Bertomeu-González; Rocio Robles; Maria J Bosch; Lorenzo Fácila; Helene Darmofal; Angel Llàcer
Journal:  Heart       Date:  2006-12-12       Impact factor: 5.994

3.  Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging.

Authors:  Sai Kiran Sharma; Melinda Wuest; Monica Wang; Darryl Glubrecht; Bonnie Andrais; Suzanne E Lapi; Frank Wuest
Journal:  EJNMMI Res       Date:  2014-11-12       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.